Recombinant human activated protein C (rhAPC, drotrecogin alfa activated) has minimal effect on markers of coagulation, fibrinolysis and inflammation in acute human endotoxemia - Derhaschnig, U; Reiter, R; Knobl, P (Blood, 2003)
et al.